Exclusive Interview with AstraZeneca’s Former VP, Medical Evidence & Observational Research Read more
Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma Read more
CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine Read more
Gemphire Therapeutics and NeuroBo Announce Merger Agreement to Advance a Neurodegenerative Disease Company Read more
Opiant Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose Read more